2007
DOI: 10.1016/j.bmcl.2006.11.092
|View full text |Cite
|
Sign up to set email alerts
|

Quinazoline and benzimidazole MCH-1R antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(6 citation statements)
references
References 10 publications
0
5
0
Order By: Relevance
“…For background to benzoheterocyclic derivatives and their applications, see: Arienzo et al (2007); Chassaing et al (2008); Galarcei et al (2008); Kumar & Rajput (2009); Kung et al (2009); Podunavac-Kuzmanovic & Cvetkovic (2010); Via et al (2001); Xue et al (2011); Zhang et al (2009). For related structures, see: Eltayeb et al (2007Eltayeb et al ( , 2009Eltayeb et al ( , 2011a.…”
Section: Related Literaturementioning
confidence: 99%
See 1 more Smart Citation
“…For background to benzoheterocyclic derivatives and their applications, see: Arienzo et al (2007); Chassaing et al (2008); Galarcei et al (2008); Kumar & Rajput (2009); Kung et al (2009); Podunavac-Kuzmanovic & Cvetkovic (2010); Via et al (2001); Xue et al (2011); Zhang et al (2009). For related structures, see: Eltayeb et al (2007Eltayeb et al ( , 2009Eltayeb et al ( , 2011a.…”
Section: Related Literaturementioning
confidence: 99%
“…Data collection: APEX2 (Bruker, 2005); cell refinement: SAINT (Bruker, 2005); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009). Benzoheterocyclic derivatives have been used widely in the pharmaceutical industry and medicine due to their diverse pharmaceutical activities (Arienzo et al, 2007;Chassaing et al, 2008;Kumar et al, 2009;Kung et al, 2009;Podunavac-Kuzmanovic & Cvetkovic, 2010;Zhang et al, 2009) including inhibition against enteroviruses (Xue et al, 2011) and potent antitumor activity (Galarcei et al, 2008;Via et al, 2001). Due to their interesting activities, the benzimidazole and quinazoline scaffolds were selected for our ongoing structural studies (Eltayeb et al, 2007;2009;2011a;2011b).…”
Section: Data Collectionmentioning
confidence: 99%
“…Quinazolinone ligands have a diverse range of pharmacological properties [1][2][3][4] and applications in several areas such as electronics, anti-corrosive agents, polymers, optical materials and fluorescent tags in DNA sequencing [5][6][7]. Recently, quinazolin-4(3H)-ones and condensed quinazolin-4(3H)-ones have been found to possess potent central nervous system activities including analgesic, anti-inflammatory and anti-convulsant effects [8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…It is present in many compounds like Vit B 12 , albendazole, mebendazole and thiabendazole which are used as antihelmintic drugs 12,13 . The 2-substituted benzimidazoles and their derivatives have been found to possess various biological activities including as inhibitors of MDA-MB-231 human breast cancer cell proliferation 14 , TRPV1 antagonists 15 , selective antagonists of the human melanocortin-4 receptor 16 , kinase inhibitors 17 , antimicrobial activity 18 and MCH-1R antagonists 19 . Benzothiophene analogues represent major class of medicinally important compound and possess wide variety of activities including vascular 5-HT 1B receptor 20 , selective inhibitors of IKK-ε kinase 21 , partial agonist activity at the benzodiazepine receptor 22 , ligands for α 1 -and 5HT 1A -receptors 23 .…”
Section: Introductionmentioning
confidence: 99%